Xheme Inc.
Newton, MA
- UEI
- C2QFNHLQHZA3
- CAGE
- 8LDG8, 9TTK3
- Primary NAICS
- 813920 Professional Organizations
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- New Hall, 100 Carlson Ave, Newton, MA 02459, USA
- Website
- xhemeinc.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Materials
- Chemicals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Center For The Advancement Of Science In Space, Inc. | 80JSC018M0005 | $497,843 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Desicorp, Inc. | Louisville, KY | 325414 Biological Product (except Diagnostic) Manufacturing |
| Hemanext Inc. | Lexington, MA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Phaxtec, Inc. | Wake Forest, NC | 325211 Plastics Material and Resin Manufacturing |
| Endomimetics, Inc. | Birmingham, AL | — |
| Tissueform, Inc. | Boulder, CO | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
About the company
Xheme Inc. is a for-profit corporate entity located in Newton, Massachusetts, registered in SAM.gov since April 2020, with a primary focus on advanced materials science and polymer engineering. The company specializes in developing innovative biomedical technologies, particularly in the realm of medical packaging and materials design. While specific details about the company's founding or complete mission are not provided, its federal grant award history demonstrates a strong commitment to developing cutting-edge, non-toxic medical storage solutions that address critical healthcare challenges.
Xheme Inc. has consistently received federal grant awards from the National Science Foundation (NSF), specifically through the Technology, Innovation, and Partnerships (TIP) and Engineering programs, focusing on developing advanced nanocomposite blood bag technologies. The company has been awarded three significant grants totaling approximately $1.7 million, with projects ranging from structure-property relationship studies to designing completely non-toxic blood bags that extend blood storage capabilities. Their research aims to replace hazardous polyvinyl chloride (PVC) blood bags with FDA-approved, non-chlorinated polymer alternatives that demonstrate improved blood cell preservation and reduced health risks. The most recent grant, a $1.193 million Cooperative Agreement awarded in September 2025, supports developing a blood bag with 25% lower red blood cell breakdown and extended shelf life. Additionally, Xheme Inc. has engaged in a sub-grant award with the Center for the Advancement of Science in Space, Inc. in January 2025, further highlighting their innovative approach to materials science and potential extraterrestrial applications.
Quick answers
Is Xheme Inc. registered in SAM.gov?
Yes. Xheme Inc.'s SAM.gov registration is active through December 19, 2026.
What are Xheme Inc.'s CAGE codes?
Xheme Inc. has 2 CAGE codes: 8LDG8 and 9TTK3. Its Unique Entity ID (UEI) is C2QFNHLQHZA3.
What is Xheme Inc.'s most recent federal award?
Xheme Inc.'s most recent federal grant award is Sttr phase II: a completely non-toxic blood bag that keeps blood healthier, longer (2527074), from National Science Foundation, on September 1, 2025.
On GovTribe
See Xheme Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors